Gainers
- AveXis, Inc. AVXS jumped 81.57 percent to close at $210.46 on Monday after the company agreed to be acquired by Novartis AG NVS for $8.7 billion.
- Turtle Beach Corporation HEAR shares gained 28.52 percent to close at $3.29 after the company raised its guidance for the first quarter.
- Red Violet, Inc. RDVT shares rose 20.69 percent to close at $9.51. red violet and Innovative Enterprises disclosed a strategic alliance to deliver advanced solutions to the background screening industry.
- Abeona Therapeutics Inc. ABEO surged 18.21 percent to close at $16.55.
- uniQure N.V. QURE shares rose 16.44 percent to close at $25.57 on Monday.
- REGENXBIO Inc. RGNX surged 15.62 percent to close at $ 31.45 after dropping 3.89 percent on Friday.
- Therapix Biosciences Ltd. TRPX rose 15.58 percent to close at $6.01. The Israel-based cannabinoid biopharmaceutical company announced encouraging phase 2a results at Yale University exploring its THX-110 among adults with Tourette syndrome. The company said its THX-100 therapy significantly improved symptoms over time in adult subjects.
- Kingtone Wirelessinfo Solution Holding Ltd KONE shares gained 15.32 percent to close at $5.12.
- Audentes Therapeutics, Inc. BOLD jumped 14.76 percent to close at $ 32.26 on Monday after dropping 2.87 percent on Friday.
- Novus Therapeutics, Inc. NVUS shares rose 14.44 percent to close at $5.47.
- Spark Therapeutics, Inc. ONCE shares surged 13.37 percent to close at $70.36.
- Aileron Therapeutics, Inc. ALRN shares rose 12.72 percent to close at $7.18.
- Intelsat S.A. I shares gained 12.48 percent to close at $5.77.
- Century Aluminum Company CENX shares climbed 12.09 percent to close at $18.82.
- Leucadia National Corporation LUK gained 11.58 percent to close at $24.29 after the company agreed to sell 48 percent of National Beef for $1.05 billion and its stake in Garcadia for $425 million. The company also announced a 25 million share buyback plan.
- Nektar Therapeutics NKTR shares rose 11.27 percent to close at $104.45.
- Verastem, Inc. VSTM shares gained 10.81 percent to close at $3.28 after the company disclosed that the FDA has accepted New Drug Application for duvelisib.
- Sage Therapeutics, Inc. SAGE shares rose 10.64 percent to close at $156.35 on Monday.
- Natera, Inc. NTRA rose 8.18 percent to close at $9.52. Natera named Paul R. Billings, M.D., Ph.D., as Chief Medical Officer. Craig-Hallum initiated coverage on Natera, with a Buy rating.
- Cellect Biotechnology Ltd. APOP gained 7.65 percent to close at $7.04. The Israel-based developer of a novel stem cell enabling technology said it has completed a proof of concept testing of its new product prototype called ApoTrainer, which is designed to replace procedures like bone marrow transplants.
- argenx SE ARGX climbed 6.73 percent to close at $79.88. argenx named Keith Woods as Chief Operating Officer. SunTrust initiated coverage on argenx with a Buy rating.
- Merck & Co., Inc. MRK rose 5.25 percent to close at $56.16 after the company disclosed that its KEYTRUDA monotherapey met its primary endpoint in the Phase 3 KEYNOTE-042 study.
Losers
- Menlo Therapeutics Inc. MNLO shares tumbled 76.8 percent to close at $8.17 on Monday. The late-stage biopharmaceutical company announced disappointing results from a phase 2 trial of its serlopitant therapy for the treatment of pruritus. The study failed to meet its primary and key secondary efficacy endpoints of showing statistically significant difference between patients who received serlopitant and those who received a placebo.
- China Internet Nationwide Financial Services Inc. CIFS shares dipped 27.88 percent to close at $21.06.
- ACADIA Pharmaceuticals Inc. ACAD shares fell 23.36 percent to close at $16.50.
- NMI Holdings, Inc. NMIH shares dropped 22.6 percent to close at $13.70.
- Mechel PAO MTL shares fell 20.89 percent to close at $3.37.
- Marrone Bio Innovations, Inc. MBII shares fell 19.38 percent to close at $2.62 on Monday after jumping 21.72 percent on Friday.
- VEON Ltd. VEON fell 17.91 percent to close at $2.20.
- MGIC Investment Corporation MTG shares dropped 17.16 percent to close at $10.62. MGIC Investment is expected to release its Q1 financial results on Wednesday, April 18, 2018.
- OncoSec Medical Incorporated ONCS shares declined 16.26 percent to close at $1.725.
- Radian Group Inc. RDN fell 15.83 percent to close at $16.11.
- Essent Group Ltd. ESNT shares declined 15.36 percent to close at $35.61.
- Netshoes (Cayman) Limited NETS shares fell 13.16 percent to close at $4.95.
- Intersections Inc. INTX shares dipped 12.95 percent to close at $1.95 on Monday.
- Mobil'nye Telesistemy PAO (ADR) MBT fell 12.55 percent to close at $9.62.
- Yandex N.V. YNDX shares dropped 12.01 percent to close at $34.66 on Monday after declining 1.84 percent on Friday.
- ArQule, Inc. ARQL shares fell 11.58 percent to close at $2.52
- Schmitt Industries, Inc. SMIT declined 9.96 percent to close at $2.44. Schmitt reported Q3 earnings of $0.00 per share, versus a year-ago loss of $0.04 per share. Its total sales rose 1.2 percent to $3.23 million.
- Twin Disc, Incorporated TWIN shares dropped 7.25 percent to close at $21.10.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: NewsMovers & ShakersPre-Market OutlookMarketsMoversTrading IdeasFinancialsLosersMovers From YesterdayMulti-Sector HoldingsTelecommunication ServicesTop GainersWireless Telecommunication ServicesYesterday's Gainers
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in